SLS
NASDAQ · Biotechnology
Sellas Life Sciences Group I
$4.93
-0.02 (-0.40%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+587.6% upside
Low Target
$25.20
Average Target
$33.90
High Target
$43.49
Current Price
$4.93
Current
$4.93
$4.93
Target
$33.90
$33.90
$25.20
$33.90 avg
$43.49
Scenario Analysis
Bear Case
$25.20
411.2%
Low target
Base Case
$33.90
+587.6%
Avg target
Bull Case
$43.49
+782.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$6.14
-19.7% from high
52-Week Low
$1.36
+262.5% from low
Target vs 52W High
$33.90
+452.1% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.04
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |